US Patent 10683302 Inhibitors of the menin-MLL interaction
Patent 10683302 was granted and assigned to Vitae Pharmaceuticals on June, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 8, 2017
0
Date of Patent
June 16, 2020
0
Patent Applicant
Patent Application Number
16308739
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10683302 Inhibitors of the menin-MLL interaction
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
